Non-Alcoholic Steatohepatitis Treatment Market Analysis 2022-2030: Focus on Cenicriviroc, Elafibranor, Ocaliva (Obeticholic Acid), Selonsertib - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

This report provides an in-depth analysis of the global nonalcoholic steatohepatitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year

By 2050, this is projected at >29 million people - a 165% increase over the 2000 level. It is to be noted that these projections imply a steady increase in the overall prevalence of diabetes, from 3.99% in 2000 to 7.21% in 2050.

However, diagnosis of the nonalcoholic steatohepatitis can be difficult to capture in an early stage and can take years before patients show any sort of symptoms which is a major factor hampering the nonalcoholic steatohepatitis treatment market.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global nonalcoholic steatohepatitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global nonalcoholic steatohepatitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nonalcoholic steatohepatitis treatment market

Company Profiles:

• AstraZeneca Plc.
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Conatus Pharmaceuticals
• Enzo Biochem, Inc.
• GENFIT SA
• Galmed Pharmaceuticals Ltd.
• Gilead Science
• Immuron Ltd.
• Intercepts Pharmaceuticals
• Novo Nordisk
• Raptor Pharmaceutical Corporation
• Tobira Therapeutics, Inc.

Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Drug
• Market Snapshot, By Distribution Channel
• Market Snapshot, By Region
• Publisher Opportunity Map

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis
• Pipeline Product Analysis
• Epidemiology Study

Global Nonalcoholic Steatohepatitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

Detailed Segmentation:

Global Nonalcoholic Steatohepatitis Treatment Market, By Drug:

• Cenicriviroc
• Elafibranor
• Ocaliva (Obeticholic Acid)
• Selonsertib

Global Nonalcoholic Steatohepatitis Treatment Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Nonalcoholic Steatohepatitis Treatment Market, By Region:

• North America
• U.S.
• Canada
• Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC
• Israel
• Rest of Middle East
• Africa
• South Africa
• Central Africa
• North Africa

For more information about this report visit https://www.researchandmarkets.com/r/t0uc4y